HCV-796

DRUG5 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

HealthyHepatic InsufficiencyHepatitis C

Phase 1

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

CompletedNCT00314054

Wyeth is now a wholly owned subsidiary of PfizerHepatic Insufficiency, Hepatitis C

Start: 2006-05-31End: 2007-10-31Target: 27Updated: 2008-04-14

Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men

CompletedNCT00385190

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2006-07-31End: 2006-12-31Target: 24Updated: 2009-08-18

Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy Subjects

CompletedNCT00407173

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2006-11-30End: 2007-06-30Target: 48Updated: 2008-04-14

HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects

CompletedNCT00410254

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2007-06-30End: 2007-08-31Target: 38Updated: 2007-12-05

Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and Desipramine

CompletedNCT00500721

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2007-06-30End: 2007-08-31Target: 22Updated: 2008-04-14